CINECA IRIS Institutional Research Information System

MARCHIO', Caterina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.675
EU - Europa 3.833
AS - Asia 1.756
AF - Africa 57
SA - Sud America 56
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.413
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.549
IT - Italia 1.240
CN - Cina 1.093
IE - Irlanda 624
SE - Svezia 394
FR - Francia 263
DE - Germania 214
AT - Austria 196
UA - Ucraina 176
VN - Vietnam 170
FI - Finlandia 164
GB - Regno Unito 142
JP - Giappone 134
PL - Polonia 118
KR - Corea 114
CA - Canada 104
IN - India 77
NL - Olanda 59
HK - Hong Kong 56
BE - Belgio 40
ES - Italia 39
CH - Svizzera 29
BR - Brasile 28
SN - Senegal 27
AU - Australia 26
RO - Romania 25
TR - Turchia 24
TW - Taiwan 23
PT - Portogallo 20
RU - Federazione Russa 18
MX - Messico 17
CL - Cile 15
NO - Norvegia 15
IR - Iran 14
GR - Grecia 12
CZ - Repubblica Ceca 8
DK - Danimarca 8
HU - Ungheria 8
NG - Nigeria 8
UZ - Uzbekistan 7
EG - Egitto 6
ZA - Sudafrica 6
ID - Indonesia 5
NZ - Nuova Zelanda 5
PK - Pakistan 5
QA - Qatar 5
RS - Serbia 5
TH - Thailandia 5
CO - Colombia 4
EU - Europa 4
MY - Malesia 4
PH - Filippine 4
SA - Arabia Saudita 4
SG - Singapore 4
BA - Bosnia-Erzegovina 3
SI - Slovenia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BM - Bermuda 2
BW - Botswana 2
JO - Giordania 2
KE - Kenya 2
PE - Perù 2
PY - Paraguay 2
SD - Sudan 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
AL - Albania 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
PS - Palestinian Territory 1
SC - Seychelles 1
SV - El Salvador 1
TN - Tunisia 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 12.413
Salva come PNG Salva come JPEG
Città #
Fairfield 697
Chandler 682
Dublin 618
Beijing 504
Houston 469
Ann Arbor 408
Torino 391
Woodbridge 360
Ashburn 305
Wilmington 265
Seattle 240
Cambridge 197
Vienna 187
Pisa 183
Villeurbanne 169
Medford 158
Princeton 157
Jacksonville 155
Nyköping 153
Redwood City 147
Dearborn 140
Warsaw 113
Dong Ket 93
New York 82
Shanghai 63
Nanjing 59
Hangzhou 55
Turin 55
Boston 54
Milan 54
San Diego 54
Guangzhou 50
Toronto 40
Fremont 39
Boardman 37
Tokyo 31
Brussels 28
Norwalk 28
Hefei 27
Ottawa 25
Chengdu 24
Falls Church 24
Phoenix 24
Rome 24
London 23
Washington 21
Wuhan 18
Silver Spring 17
Chicago 16
Upper Marlboro 16
Jinan 15
Paris 15
Fuzhou 14
Hebei 14
Pittsburgh 14
Taipei 14
Central District 13
Changsha 13
Fosses 13
Chongqing 12
Kunming 12
Mountain View 12
Seoul 12
Zhengzhou 12
Carrara 11
Zola Predosa 11
Bologna 10
Columbus 10
Nagoya 10
Philadelphia 10
Redmond 10
San Jose 10
Hanover 9
Los Angeles 9
San Francisco 9
Santiago 9
Shenyang 9
Verona 9
Xian 9
Abuja 8
Auburn Hills 8
Delhi 8
Lexington 8
Madrid 8
Moncalieri 8
Mumbai 8
Napoli 8
Tianjin 8
Berlin 7
Buffalo 7
Central 7
Dallas 7
Hamilton 7
Nanchang 7
Ningbo 7
Porto 7
San Mateo 7
Basel 6
Florence 6
Gainesville 6
Totale 8.262
Salva come PNG Salva come JPEG
Nome #
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands 618
Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors 308
BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS Mutant Colorectal Cancer 289
Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples 246
Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis. 235
Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies. 219
SF3B1mutations constitute a novel therapeutic target in breast cancer 218
Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast 216
A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits 196
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer. 179
Distinctive pathological and clinical features of lung carcinoids with high proliferation index 176
High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breast 168
Awareness of mutational artefacts in suboptimal DNA samples: possible risk for therapeutic choices 164
The expression of growth hormone releasing hormone (GHRH) and its receptors in breast carcinomas with apocrine differentiation - further evidence of the presence of a GHRH pathway in these tumors 159
miR-221/222 control luminal breast cancer tumor progression by regulating different targets 156
Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues 155
Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes 155
Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis 152
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines. 145
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family 145
Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers 145
Personalized therapeutic strategies in HER2-driven gastric cancer 142
HER2 in Breast Cancer 139
Pleomorphism of the Nuclear Envelope in breast cancer: a new approach to an old problem 136
A collection of primary tissue cultures of tumors from vacuum packed and cooled surgical specimens: a feasibility study 136
Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box 135
Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond 135
The perfect pathology report after neoadjuvant therapy 134
Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues 133
Classification of pulmonary neuroendocrine tumors: New insights 132
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study 128
The impact of malignant nipple discharge cytology (NDc) in surgical management of breast cancer patients 127
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment 127
THE EXPRESSION OF LINE1-MET CHIMERIC TRANSCRIPT IDENTIFIES A SUBGROUP OF AGGRESSIVE BREAST CANCERS 126
“To Be or Not to Be in a Good Shape”: Diagnostic and Clinical Value of Nuclear Shape Irregularities in Thyroid and Breast Cancer 125
Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function 123
Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells. 122
Tissue arrays as fiducial markers for section alignment in 3-D reconstruction technology 122
Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study 120
PAX8–GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid 117
Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene 113
Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression Profiling 111
Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization 104
CUTseq is a versatile method for preparing multiplexed DNA sequencing libraries from low-input samples 103
Assessment of a High Sensitivity Method for Identification of IDH1 R132x Mutations in Tumors and Plasma of Intrahepatic Cholangiocarcinoma Patients 101
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression 98
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study 97
Small-cell carcinoma of the breast with squamous differentiation 95
CXCL12 expression is a bona fide predictor of recurrence in lung neuroendocrine tumours; a multicentric study with emphasis on atypical carcinoids - a short report 89
The Multifaceted Nature of Tumor Microenvironment in Breast Carcinomas 89
Rediscovering secondary tumors of the prostate in the molecular era 88
ESR1 mutations in metastatic lobular breast cancer patients 84
The genetic landscape of breast carcinomas with neuroendocrine differentiation 81
Pathology and Molecular Pathology of Breast Cancer 81
RollFISH achieves robust quantification of single-molecule RNA biomarkers in paraffin-embedded tumor tissue samples 80
Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study 79
Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach? 79
Predictive Diagnostic Pathology in the Target Therapy Era in Breast Cancer 77
Caveolin 1 expression favors tumor growth and is associated with poor survival in primary lung adenocarcinomas 77
Reccomendations for using of molecular assays on liquid biopsy: The first document provided by intersociety Group AIOM, SIF, SIAPEC-IAP, SIBioC 77
Breast cancer precursors revisited: molecular features and progression pathways. 76
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 76
Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer 76
Breast carcinomas with low amplified/equivocal HER2 by Ish: Potential supporting role of multiplex ligation-dependent probe amplification 75
Traditional urinary cytology and tyrosinase RT-PCR in metastatic melanoma patients: correlation with clinical status 74
Cold Formalin Fixation Guarantees DNA Integrity in Formalin Fixed Paraffin Embedded Tissues: Premises for a Better Quality of Diagnostic and Experimental Pathology With a Specific Impact on Breast Cancer 73
Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor 71
CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification. 70
Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast 69
Pursuit of Gene Fusions in Daily Practice: Evidence from Real-World Data in Wild-Type and Microsatellite Instable Patients 69
Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure 68
PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas 64
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. 63
Neoplastic cell percentage estimation in tissue samples for molecular oncology: recommendations from a modified Delphi study 63
The role of molecular analysis in breast cancer. 62
Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas). 61
Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment. 60
Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast 59
Chemotherapy with or without trastuzumab. 59
Gene Status in HER2 Equivocal Breast Carcinomas: Impact of Distinct Recommendations and Contribution of a Polymerase Chain Reaction-Based Method. 59
Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype? 58
Breast Cancer Heterogeneity: Roles in Tumorigenesis and Therapeutic Implications 58
Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes 58
Optimized EGFR blockade strategies in EGFR addicted gastroesophageal adenocarcinomas 58
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis 57
Inclusion of platinum agents in neoadjuvant chemotherapy regimens for triple-negative breast cancer patients: Development of GRADE (grades of recommendation, assessment, development and evaluation) recommendation by the Italian association of medical oncology (AIOM) 57
Reoperation rate after breast conserving surgery as quality indicator in breast cancer treatment: A reappraisal 57
Tiling path genomic profiling of grade 3 invasive ductal breast cancers. 56
Well-differentiated neuroendocrine tumour of the breast showing peculiar endovascular spread. 55
Synthetic lethality screening highlights colorectal cancer vulnerability to concomitant blockade of nedd8 and egfr pathways 55
RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers 55
AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells 54
Genetic analysis of a morphologically heterogeneous ovarian endometrioid carcinoma 51
Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis. 50
Tissues under-vacuum to overcome suboptimal preservation 50
The ENDOPREDICT® molecular test for breast cancer prognosis: clinical-pathological correlations and therapeutic implications on a selected cohort of patients 50
The pathologic complete response open question in primary therapy 49
The genomic profile of HER2-amplified breast cancers: the influence of ER status 49
Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast 48
Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components 48
Totale 11.126
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.641
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.268 0 0 48 65 89 55 62 171 72 142 383 181
2019/20202.444 125 117 112 285 177 380 264 225 313 176 148 122
2020/20211.956 104 131 139 127 141 160 199 106 191 218 148 292
2021/20222.090 101 122 152 207 127 97 127 145 84 165 395 368
2022/20232.655 270 175 75 194 266 631 268 179 284 77 138 98
2023/2024420 167 187 66 0 0 0 0 0 0 0 0 0
Totale 12.914